Lavipharm Group Holding S.A. – Trademark Portfolio
Entity Type: 03
Lavipharm Group Holding S.A. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 6 Nice Classification classes. The owner is based in L-1341 Luxembourg.
9, rue Clairefontaine
L-1341 Luxembourg , LU
Showing of trademarks Trademarks
Trademark Classifications
Lavipharm Group Holding S.A.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Advertising; business management; business administration; office functions
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Lavipharm Group Holding S.A. have?
Lavipharm Group Holding S.A. has 19 U.S. trademarks filed with the USPTO.
What trademark classes does Lavipharm Group Holding S.A. file in?
Lavipharm Group Holding S.A. files trademarks across 6 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 29 (Meats & Processed Foods), Class 35 (Advertising & Business), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is Lavipharm Group Holding S.A.'s trademark registration success rate?
Lavipharm Group Holding S.A. has a 0% trademark registration rate, with 0 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.